Exchange Announcement • 11 Dec 2024 15:00
Exchange Announcement • 02 Dec 2024 14:58
Exchange Announcement • 25 Nov 2024 14:30
Exchange Announcement • 07 Nov 2024 17:12
Exchange Announcement • 07 Nov 2024 15:46
ENTITY
Isu Abxis (086890 KS)
Isu Abxis (086890 KS)
1
Analysis
Health Care • South Korea
ISU ABXIS Co., Ltd. develops therapeutic antibodies for such as antithrombus, anti-inflammatory, anti-cancer, and rare diseases. The Company also provides medical service such as anti-cancer drug sensitivity examination and gene examination.
more
x